Contrary to conventional wisdom, American consumers are not subsidizing lower drug prices around the world by paying higher prices for their prescription medications in the U.S., a Wharton School professor argued Wednesday.
North
Jersey Media Group
Simplifying Global Compliance
Recommended Products
GMP Inspection Preparation Checklist: A Tool for Internal Auditing
This management report includes more than 650 items organized in three sections covering all aspects of quality manufacturing.
Biological Risk Evaluation and Management for Medical Devices
Report shows how the FDA incorporates the two ISO standards in its medical device development policy, how the EU version of the two standards differs in significant ways and how the EU Medical Device Regulation may require further changes in the European standards.
Editor's Picks
Kleresca Approved in EU for Dermatological Platform
The treatment does not damage the skin’s natural barriers.
Pro-Kratom Nonprofit Pushes Back on Deaths FDA Attributed to Substance
The FDA issued warning letters in May to three U.S. distributors of more than 65 kratom products for sales of unapproved new drugs claiming effectiveness in treating opioid addiction and withdrawal.
FDAnews Drug Daily Bulletin
ANALYST: DRUGS OVERSEAS COSTLY, TOO
May 12, 2006